Shots:
- Medtronic has entered into a definitive agreement to acquire Scientia Vascular, expanding its neurovascular device portfolio
- As per the deal, Medtronic will acquire Scientia Vascular for $550M, with potential undisclosed earn-out & milestone payments post-acquisition
- Acquisition will integrate Scientia’s access platform with Medtronic’s neurovascular therapies to support the full procedural workflow for hemorrhagic & ischemic stroke
Ref: Medtronic | Image: Scientia Vascular | Press Release
Related News: Medtronic Reports 510(k) Clearance of MiniMed Go System for Diabetes Management
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
